Amlobika HCT Tablets 10/40/12.5mg

Adult dose

This medication should be taken once daily, 1 tablet, with or without food. It is recommended to take it at the same time every day (e.g., in the morning). The starting dose may range from 5/20/12.5mg with gradual increases up to a maximum of 10/40/25mg based on blood pressure control. Each dose adjustment should be made at an interval of more than 2 weeks. Dose adjustment and monitoring for renal impairment, liver impairment, and older adults are required.

Child dose

The safety and efficacy for pediatric patients under 18 years have not been established, and the use of this medication is not recommended.

This medication can cause serious damage to the fetus and newborn during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, the medication should be discontinued immediately. Patients who have allergies to this medication or its components, or have specific heart, kidney, or liver diseases, pregnant women, and nursing mothers should not take this medication. Patients with reduced blood volume, decreased kidney function, weak liver function, or specific heart conditions should use this medication cautiously and should be closely monitored as hypotension or changes in kidney function may occur. As this medication has blood pressure-lowering effects, it may cause dizziness or lightheadedness, so caution is advised when driving or operating dangerous machinery. This medication may affect electrolyte balance in the blood, especially potassium, sodium, calcium, and magnesium levels; therefore, regular blood tests should be performed to monitor the condition. While taking this medication, the skin may become sensitive to sunlight; thus, it's recommended to avoid sun exposure or take appropriate protective measures. This medication can interact with various other drugs, so if you are taking other medications, you must inform your doctor or pharmacist, especially when used together with lithium, diuretics, antihypertensives, or non-steroidal anti-inflammatory drugs (NSAIDs). In case of overdose, symptoms including hypotension, palpitations, and in severe cases, cardiac function deterioration can occur, and immediate medical help should be sought. This medication's safety and effectiveness for children have not been established, and dosage adjustment may be necessary for the elderly considering decreased liver and kidney function. It is advisable for nursing women to avoid using this medication, and if necessary, consider stopping breastfeeding or alternative treatment options. This medication should be stored at appropriate temperatures and humidity, and kept out of reach of children.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, severe allergic reactions, severe rashes with high fever, blisters, skin peeling, pain in oral/ocular mucous membranes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attack, respiratory distress with coughing and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, liver dysfunction (jaundice), sudden and severe headache, thunderclap headache.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is important to maintain storage temperatures between 1-30 degrees Celsius to preserve the medication's effectiveness and safety over time.

Appearance

Round film-coated tablets of reddish-gray color

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]